Michael G. Fitzpatrick sold Medtronic PLC (NYSE: MDT)
Michael G. Fitzpatrick (R-PA), a U.S. Representative, has disclosed 1 trade in Medtronic PLC (MDT) since 2014, a single purchase.
The trade highlighted here is a sale: Michael G. Fitzpatrick sold Unknown of Medtronic PLC (NYSE: MDT) on January 27, 2014. Since that trade, MDT is up +108.50% against the S&P 500 up +404.50%, an outperformance of -296.00%.
Data updated
Michael G. Fitzpatrick's MDT trades vs the price
MDT is up +108.50% since Michael G. Fitzpatrick sold on January 27, 2014, versus +404.50% for the S&P 500.
Performance since this trade
All Michael G. Fitzpatrick MDT trades
Michael G. Fitzpatrick & MDT trading FAQ
Is it legal for Michael G. Fitzpatrick to trade Medtronic PLC (MDT) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Medtronic PLC (MDT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Michael G. Fitzpatrick sell MDT?
Michael G. Fitzpatrick disclosed a sale of Unknown of Medtronic PLC (MDT) on January 27, 2014, according to public STOCK Act filings.
How has MDT performed since Michael G. Fitzpatrick's trade?
Since Michael G. Fitzpatrick sold MDT on January 27, 2014, the stock is up +108.50%, versus +404.50% for the S&P 500 over the same period, an outperformance of -296.00%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional MDT trades?
Quantellect tracks every disclosed congressional trade in Medtronic PLC (MDT) on the Medtronic PLC congressional trading page, which aggregates filings across all members of Congress.
Michael G. Fitzpatrick's MDT tradesAll congressional filings for Medtronic PLCMichael G. Fitzpatrick's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.